The global isosorbide mononitrate market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Isosorbide mononitrate is sold under many brand names and belongs to the dug class that are aimed at reducing heart-related chest pain and treating conditions such as esophageal spasms and heart failure. Though it is generally less preferred than calcium channel blockers or beta blockers, it can be used as both as a preventive medication as well as for treating heart-related chest pain. The drug is thus used to prevent angina (chest pain) resulting from coronary artery disease (heart disease). The global isosorbide mononitrate market growth is majorly attributable to growing cases of cardiovascular diseases, particularly the coronary artery disease that cause angina or chest pain.
Chest pain is one of the most commonly observed symptoms of various medical conditions such as acid reflux, heart burn, and gastritis. However, the pain caused by heart related disease needs to be immediately addressed so as to avoid further complications. Almost 15 million people all over the globe suffer from heart attacks or similar issues, according to the World Heart Federation. Between 2016 and 2017, the US spent $363 billion on heart disease. Among the various types of heart ailments, the most frequent type of heart illness, coronary heart disease, affect approximately 18.2 million persons aged 20 and up (about 6.7%). Such estimates lead to an increased demand for effective solutions such as isosorbide mononitrate. This is likely to create promising opportunities for the global isosorbide mononitrate market during the forecast period.
(Get 15% Discount on Buying this Report)
Get Sample Copy of isosorbide mononitrate market at:
https://orionmarketreports.com/request-sample/?id=94053&submit=Request+Sample%0D%0A
Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
Regions covered-
North America
Europe
Asia-Pacific
Rest of the World
Top Major Key Players:
Novartis International AG, Teva Pharmaceutical Industries Ltd., and AstraZeneca plc, among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?
A full report of isosorbide mononitrate market is available at:
https://orionmarketreports.com/global-isosorbide-mononitrate-market/94053/
Global Isosorbide Mononitrate Market Report by Segment
By Type
10 mg
20 mg
By Application
Clinics
Hospitals
Others
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
